Electronic Reporting

Electronic Reporting of Suspected Unexpected Serious Adverse Events (SUSARS) is now mandatory in many global territories. Almond Pharma handles the onerous task of registration and setting up electronic reporting routes for the Pharmacovigilance system. Experienced and trained personnel ensure that expedited reporting meets the regulatory requirements in each trial territory. Whether electronic or hard copy, we offer consolidated expedited reporting services.

© 2022 ASAAL ltd
Registered in the UK, Company number 06830591

Back to top